Cybin Corp

CYBN
NYSE AMERICAN: CYBN
Request Investor Info

Cybin is a biotech company in the psychedelic therapeutic sector. Their team is focused on the development of mental healthcare treatment with a single-minded goal to dramatically improve patient outcomes versus currently available pharmacotherapies.

Projects
Stories
Presentation
Contact
Management
Financials
Cybin Corp Stock Price Today
Cybin Corp Fundamental Data by TradingView

Company Feed

Cybin
January 17, 2022

Investor Alert - Cybin: Changing the Mental Healthcare Experience

Cybin is a biotech company in the psychedelic therapeutic sector. Their team is focused on the development of mental healthcare treatment with a singl …

This is some text inside of a div block.
Cybin pyschedelic mental health
May 28, 2021

Cybin: Changing Mental Healthcare with Psychedelics

Cybin is on a mission to revolutionize mental healthcare. They're focusing on progressing psychedelic therapeutics by utilizing proprietary drug disco …

This is some text inside of a div block.
Cybin psychedelic mental health
May 5, 2021

Cybin: Psychedelic Therapies to Treat Mental Illness

Cybin Inc.'s primary focus is to take classical psychedelic molecules and transform them into useful therapeutic agents for mental health disorders. " …

This is some text inside of a div block.
Cybin psychedelics Cybin pschedelic medicine mental health
April 26, 2021

Cybin: Revolutionizing Mental Healthcare

Cybin is focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel fo …

This is some text inside of a div block.
Subscribe and receive the investor Info